1.22.01: Pharmaceuticals Issue
Six leading analysts and top management from seventeen sector firms examine Pharmaceuticals companies in this special 96-page issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    First Union Securities 2nd Annual Brain & Spine Symposium & JP Morgan H&Q 19th Healthcare Conference

  1. Pharmaceuticals - In an in-depth (20,000 words) Analyst Roundtable, Mario Corso, Senior Analyst at ABN AMRO, Inc., Jeffrey Kraws, Pharmaceutical Analyst at Gruntal & Company, L.L.C., D. Larry Smith, Pharmaceutical Analyst at Sutro & Company, Sergio Traversa, Pharmaceutical Analyst at ING Barings, L.L.C., and Leonard Yaffe, Pharmaceutical Analyst at Banc of America Securities, examine the outlook for the sector, including pricing trends, new product pipelines and share specific stock recommendations.
  2. Outlook for Pharmaceutical Stocks - In an in-depth (3,300 words) Analyst Interview, C. Anthony Butler, Managing Director at Lehman Brothers, examines the outlook for the sector, including patent expiration cycle, differentiates among the product pipelines at the major pharmas, and shares specific stock recommendations.
  3. The TWST confidential Off-The-Record survey of management performance at nine sector firms asked market insiders about the ability of management teams to create shareholder value. Firms reviewed in Off-The-Record include:
    American Home Products, Amgen, Aviron, Bristol-Myers Squibb, Eli Lilly & Company, Merck & Co., Pfizer, Pharmacia, Schering-Plough
  4. CEO interviews (average 2,500 words). Top management of seventeen sector firms examine the outlook for their firm and the sector. Firms include:
    Procyon BioPharma, aaiPharma, Bentley Pharmaceuticals, Bone Care International, Hypertension Diagnostics, Hi-Tech Pharmacal Co., IMI International Medical Innovations, Innovative Clinical Solutions, IntraBiotics Pharmaceuticals, ISTA Pharmaceuticals, IVAX, MediChem Life Sciences, Neurochem, Paladin Labs, Sharps Compliance, Spectral Diagnostics, Women First HealthCare
    5. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE